These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 12063279

  • 1. Increasing P(50) does not improve DO(2CRIT) or systemic VO(2) in severe anemia.
    Eichelbrönner O, D'Almeida M, Sielenkämper A, Sibbald WJ, Chin-Yee IH.
    Am J Physiol Heart Circ Physiol; 2002 Jul; 283(1):H92-101. PubMed ID: 12063279
    [Abstract] [Full Text] [Related]

  • 2. Effects of FI(O(2)) on hemodynamic responses and O(2) transport during RSR13-induced reduction in P(50).
    Eichelbrönner O, Sielenkämper A, D'Almeida M, Ellis CG, Sibbald WJ, Chin-Yee IH.
    Am J Physiol; 1999 Jul; 277(1):H290-8. PubMed ID: 10409208
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. RSR13, a synthetic allosteric modifier of hemoglobin, improves myocardial recovery following hypothermic cardiopulmonary bypass.
    Kilgore KS, Shwartz CF, Gallagher MA, Steffen RP, Mosca RS, Bolling SF.
    Circulation; 1999 Nov 09; 100(19 Suppl):II351-6. PubMed ID: 10567328
    [Abstract] [Full Text] [Related]

  • 5. Effects of RSR13, a synthetic allosteric modifier of hemoglobin, alone and in combination with dizocilpine, on outcome from transient focal cerebral ischemia in the rat.
    Sarraf-Yazdi S, Sheng H, Grocott HP, Bart RD, Pearlstein RD, Steffen RP, Warner DS.
    Brain Res; 1999 May 01; 826(2):172-80. PubMed ID: 10224294
    [Abstract] [Full Text] [Related]

  • 6. Phase I trial to determine the safety, pharmacodynamics, and pharmacokinetics of RSR13, a novel radioenhancer, in newly diagnosed glioblastoma multiforme.
    Kleinberg L, Grossman SA, Piantadosi S, Pearlman J, Engelhard H, Lesser G, Ruffer J, Gerber M.
    J Clin Oncol; 1999 Aug 01; 17(8):2593-603. PubMed ID: 10561327
    [Abstract] [Full Text] [Related]

  • 7. Allosteric modification of oxygen delivery by hemoglobin.
    Wahr JA, Gerber M, Venitz J, Baliga N.
    Anesth Analg; 2001 Mar 01; 92(3):615-20. PubMed ID: 11226087
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of a synthetic allosteric modifier of hemoglobin oxygen affinity on outcome from global cerebral ischemia in the rat.
    Grocott HP, Bart RD, Sheng H, Miura Y, Steffen R, Pearlstein RD, Warner DS.
    Stroke; 1998 Aug 01; 29(8):1650-5. PubMed ID: 9707208
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of oxygen affinity on systemic perfusion and brain tissue oxygen tension after extreme hemodilution with hemoglobin-starch conjugates in rats.
    Hare GM, Liu E, Baker AJ, Mazer CD.
    Intensive Care Med; 2009 Nov 01; 35(11):1925-33. PubMed ID: 19590850
    [Abstract] [Full Text] [Related]

  • 15. RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice.
    Khandelwal SR, Kavanagh BD, Lin PS, Truong QT, Lu J, Abraham DJ, Schmidt-Ullrich RK.
    Br J Cancer; 1999 Feb 01; 79(5-6):814-20. PubMed ID: 10070874
    [Abstract] [Full Text] [Related]

  • 16. Tissue oxidative metabolism after extreme hemodilution with PEG-conjugated hemoglobin.
    Cabrales P, Meng F, Acharya SA.
    J Appl Physiol (1985); 2010 Dec 01; 109(6):1852-9. PubMed ID: 20813980
    [Abstract] [Full Text] [Related]

  • 17. RSR13, a synthetic allosteric modifier of hemoglobin, as an adjunct to radiotherapy: preliminary studies with EMT6 cells and tumors and normal tissues in mice.
    Rockwell S, Kelley M.
    Radiat Oncol Investig; 1998 Dec 01; 6(5):199-208. PubMed ID: 9822166
    [Abstract] [Full Text] [Related]

  • 18. Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation.
    Khandelwal SR, Randad RS, Lin PS, Meng H, Pittman RN, Kontos HA, Choi SC, Abraham DJ, Schmidt-Ullrich R.
    Am J Physiol; 1993 Oct 01; 265(4 Pt 2):H1450-3. PubMed ID: 8238433
    [Abstract] [Full Text] [Related]

  • 19. Effects of a pharmacologically-induced shift of hemoglobin-oxygen dissociation on myocardial energetics during ischemia in patients with coronary artery disease.
    Najjar SS, Bottomley PA, Schulman SP, Waldron MM, Steffen RP, Gerstenblith G, Weiss RG.
    J Cardiovasc Magn Reson; 2005 Oct 01; 7(4):657-66. PubMed ID: 16136855
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.